Cargando…

Managing the cancer backlog: a national population-based study of patient mobility, waiting times and ‘spare capacity’ for cancer surgery

BACKGROUND: Waiting times for cancer treatments continue to increase in many countries. In this study we estimated potential ‘spare surgical capacity’ in the English NHS and identified regions more likely to have spare capacity based on patterns of patient mobility (the extent to which patients rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Ajay, Han, Lu, Sullivan, Richard, Haire, Kate, Sangar, Vijay, van der Meulen, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350851/
https://www.ncbi.nlm.nih.gov/pubmed/37465324
http://dx.doi.org/10.1016/j.lanepe.2023.100642
_version_ 1785074228925562880
author Aggarwal, Ajay
Han, Lu
Sullivan, Richard
Haire, Kate
Sangar, Vijay
van der Meulen, Jan
author_facet Aggarwal, Ajay
Han, Lu
Sullivan, Richard
Haire, Kate
Sangar, Vijay
van der Meulen, Jan
author_sort Aggarwal, Ajay
collection PubMed
description BACKGROUND: Waiting times for cancer treatments continue to increase in many countries. In this study we estimated potential ‘spare surgical capacity’ in the English NHS and identified regions more likely to have spare capacity based on patterns of patient mobility (the extent to which patients receive surgery at hospitals other than their nearest). METHODS: We identified patients who had an elective breast or colorectal cancer surgical resection between January 2016 and December 2018. We estimated each hospital's ‘maximum surgical capacity’ as the maximum 6-month moving average of its surgical volume. ‘Spare surgical capacity’ was estimated as the difference between maximum surgical capacity and observed surgical volume. We assessed the association between spare surgical capacity and whether a hospital performed more or fewer procedures than expected due to patient mobility as well as the association between spare surgical capacity and whether or not waiting times targets for treatment were likely to be met. FINDINGS: 100,585 and 49,445 patients underwent breast and colorectal cancer surgery respectively. 67 of 166 hospitals (40.4%) providing breast cancer surgery and 82 of 163 hospitals (50.3%) providing colorectal cancer surgery used less than 80% of their maximum surgical capacity. Hospitals with a ‘net loss’ of patients to hospitals further away had more potential spare capacity than hospitals with a ‘net gain’ of patients (p < 0.001 for breast and p = 0.01 for colorectal cancer). At the national level, we projected an annual potential spare capacity of 8389 breast cancer and 4262 colorectal cancer surgical procedures, approximately 25% of the volumes actually performed. INTERPRETATION: Spare surgical capacity potentially exists in the present configuration of hospitals providing cancer surgery and requires regional allocation for efficient utilisation. FUNDING: 10.13039/501100000272National Institute for Health Research.
format Online
Article
Text
id pubmed-10350851
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103508512023-07-18 Managing the cancer backlog: a national population-based study of patient mobility, waiting times and ‘spare capacity’ for cancer surgery Aggarwal, Ajay Han, Lu Sullivan, Richard Haire, Kate Sangar, Vijay van der Meulen, Jan Lancet Reg Health Eur Articles BACKGROUND: Waiting times for cancer treatments continue to increase in many countries. In this study we estimated potential ‘spare surgical capacity’ in the English NHS and identified regions more likely to have spare capacity based on patterns of patient mobility (the extent to which patients receive surgery at hospitals other than their nearest). METHODS: We identified patients who had an elective breast or colorectal cancer surgical resection between January 2016 and December 2018. We estimated each hospital's ‘maximum surgical capacity’ as the maximum 6-month moving average of its surgical volume. ‘Spare surgical capacity’ was estimated as the difference between maximum surgical capacity and observed surgical volume. We assessed the association between spare surgical capacity and whether a hospital performed more or fewer procedures than expected due to patient mobility as well as the association between spare surgical capacity and whether or not waiting times targets for treatment were likely to be met. FINDINGS: 100,585 and 49,445 patients underwent breast and colorectal cancer surgery respectively. 67 of 166 hospitals (40.4%) providing breast cancer surgery and 82 of 163 hospitals (50.3%) providing colorectal cancer surgery used less than 80% of their maximum surgical capacity. Hospitals with a ‘net loss’ of patients to hospitals further away had more potential spare capacity than hospitals with a ‘net gain’ of patients (p < 0.001 for breast and p = 0.01 for colorectal cancer). At the national level, we projected an annual potential spare capacity of 8389 breast cancer and 4262 colorectal cancer surgical procedures, approximately 25% of the volumes actually performed. INTERPRETATION: Spare surgical capacity potentially exists in the present configuration of hospitals providing cancer surgery and requires regional allocation for efficient utilisation. FUNDING: 10.13039/501100000272National Institute for Health Research. Elsevier 2023-05-03 /pmc/articles/PMC10350851/ /pubmed/37465324 http://dx.doi.org/10.1016/j.lanepe.2023.100642 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles
Aggarwal, Ajay
Han, Lu
Sullivan, Richard
Haire, Kate
Sangar, Vijay
van der Meulen, Jan
Managing the cancer backlog: a national population-based study of patient mobility, waiting times and ‘spare capacity’ for cancer surgery
title Managing the cancer backlog: a national population-based study of patient mobility, waiting times and ‘spare capacity’ for cancer surgery
title_full Managing the cancer backlog: a national population-based study of patient mobility, waiting times and ‘spare capacity’ for cancer surgery
title_fullStr Managing the cancer backlog: a national population-based study of patient mobility, waiting times and ‘spare capacity’ for cancer surgery
title_full_unstemmed Managing the cancer backlog: a national population-based study of patient mobility, waiting times and ‘spare capacity’ for cancer surgery
title_short Managing the cancer backlog: a national population-based study of patient mobility, waiting times and ‘spare capacity’ for cancer surgery
title_sort managing the cancer backlog: a national population-based study of patient mobility, waiting times and ‘spare capacity’ for cancer surgery
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350851/
https://www.ncbi.nlm.nih.gov/pubmed/37465324
http://dx.doi.org/10.1016/j.lanepe.2023.100642
work_keys_str_mv AT aggarwalajay managingthecancerbackloganationalpopulationbasedstudyofpatientmobilitywaitingtimesandsparecapacityforcancersurgery
AT hanlu managingthecancerbackloganationalpopulationbasedstudyofpatientmobilitywaitingtimesandsparecapacityforcancersurgery
AT sullivanrichard managingthecancerbackloganationalpopulationbasedstudyofpatientmobilitywaitingtimesandsparecapacityforcancersurgery
AT hairekate managingthecancerbackloganationalpopulationbasedstudyofpatientmobilitywaitingtimesandsparecapacityforcancersurgery
AT sangarvijay managingthecancerbackloganationalpopulationbasedstudyofpatientmobilitywaitingtimesandsparecapacityforcancersurgery
AT vandermeulenjan managingthecancerbackloganationalpopulationbasedstudyofpatientmobilitywaitingtimesandsparecapacityforcancersurgery